Your browser doesn't support javascript.
loading
Are the odds shifting against pharma in the fight for cheaper treatment for macular degeneration?
BMJ ; 359: j5016, 2017 10 31.
Article in En | MEDLINE | ID: mdl-29089312

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiogenesis Inhibitors / Medication Therapy Management / Wet Macular Degeneration / Bevacizumab Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: BMJ Journal subject: MEDICINA Year: 2017 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiogenesis Inhibitors / Medication Therapy Management / Wet Macular Degeneration / Bevacizumab Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: BMJ Journal subject: MEDICINA Year: 2017 Document type: Article Country of publication: United kingdom